8-K: Schwazze Reports Full Year 2023 Revenue of $172.4 Million, Achieves $53.4 Million Adjusted EBITDA
Quarterly Report
Schwazze announced its fourth quarter and full year 2023 financial results, highlighting $172.4 million in revenue and $53.4 million in adjusted EBITDA for the year.
Summary
- Schwazze reported full year 2023 revenue of $172.4 million, with an adjusted EBITDA of $53.4 million, representing 31% of revenue.
- The company generated $12.2 million in operating cash flow for the full year 2023.
- In the fourth quarter of 2023, total revenue reached $43.3 million, an 8% increase compared to the same quarter last year.
- However, gross profit for Q4 2023 was $7.0 million, down from $21.7 million in Q4 2022, primarily due to $13.1 million in non-cash inventory adjustments.
- Adjusted gross profit for Q4 2023 was $20.2 million, or 46.6% of revenue.
- The company's operating expenses for Q4 2023 were $23.3 million, a slight decrease from $24.2 million in the same quarter last year.
- The loss from operations for Q4 2023 was $16.2 million, compared to a loss of $2.5 million in Q4 2022.
- Adjusted EBITDA for Q4 2023 was $11.0 million, or 25.3% of revenue, down from $13.3 million, or 33.1% of revenue, in the same quarter last year.
- As of December 31, 2023, cash and cash equivalents were $19.2 million, compared to $38.9 million on December 31, 2022.
- Total debt as of December 31, 2023, was $156.8 million, compared to $127.8 million on December 31, 2022.
Sentiment
Score: 5
Explanation: The document presents a mixed picture with strong revenue growth and EBITDA for the year, but a concerning decrease in profitability and cash flow in the fourth quarter. The company faces significant competitive pressures and increased debt, which tempers the positive aspects.
Positives
- The company achieved solid top-line growth in competitive markets.
- Schwazze demonstrated improved operating cash flow in 2023.
- The company expanded its retail footprint significantly, increasing the number of dispensaries by more than 50%.
- Wholesale penetration increased substantially year-over-year.
- Lowell Farms pre-roll sales saw significant growth, becoming the top pre-roll in Colorado.
- Wana gummies sales also experienced substantial growth in New Mexico.
- The company is focused on maximizing operating efficiencies in manufacturing and cultivation facilities.
- Schwazze significantly outpaced the market in Q4 on a sequential and year-over-year basis.
Negatives
- Gross profit for the fourth quarter of 2023 decreased significantly due to non-cash inventory adjustments.
- The company experienced a loss from operations in the fourth quarter of 2023.
- Adjusted EBITDA margin decreased in the fourth quarter of 2023 due to higher operating expenses.
- Cash and cash equivalents decreased from $38.9 million to $19.2 million year-over-year.
- Total debt increased from $127.8 million to $156.8 million year-over-year.
- The Colorado and New Mexico markets were pressured in 2023.
- Increased competition and aggressive pricing strategies in New Mexico led to lower average revenue per store.
Risks
- The cannabis market in Colorado and New Mexico is highly competitive.
- The proliferation of new licenses in New Mexico has led to increased competition and pricing pressure.
- The company faces challenges in maintaining profitability due to market pressures and increased operating expenses.
- There are risks associated with regulatory limitations and changes in laws.
- The company's ability to access adequate capital is a potential risk.
- Volatility in credit and market conditions could impact the company's performance.
- The loss of key executives or employees could negatively affect the business.
Future Outlook
The company is optimistic about regulatory momentum in the industry and will focus on enhancing customer experience, improving loyalty programs, increasing cost efficiencies, and enhancing retail assets. They expect to drive growth and profitability across their markets in 2024.
Management Comments
- The Schwazze team delivered solid top-line growth in two highly competitive markets with 31% adjusted EBITDA margins and improved operating cash flow, said Forrest Hoffmaster, Interim CEO of Schwazze.
- We continued to sharpen our retail strategy while expanding our store footprint by more than 50% to 63 dispensaries across our two markets.
- We significantly outpaced the market in Q4 on a sequential and year-over-year basis and expect to bolster our growth through improvements in customer acquisition, retention, and loyalty, as well as in the overall retail experience.
- We remain focused on cost optimization and asset utilization while implementing a balanced pricing and promotional strategy to drive traffic into our stores, where we believe we excel in delivering an elevated retail experience.
Industry Context
The announcement reflects the challenges and opportunities in the competitive cannabis market, particularly in Colorado and New Mexico, where increased competition and pricing pressures are impacting performance. The company's focus on customer experience and operational efficiencies aligns with industry trends.
Comparison to Industry Standards
- Schwazze's adjusted EBITDA margin of 31% for the full year is a strong result compared to many cannabis companies, but the Q4 margin of 25.3% shows a decline.
- Companies like Curaleaf and Green Thumb Industries, which are larger multi-state operators, often report higher revenue figures but may have different profitability profiles.
- The expansion of retail footprint by 50% is significant, but the impact on revenue per store in New Mexico highlights the challenges of rapid expansion in a competitive market.
- The 3x increase in wholesale penetration is a positive sign, indicating a growing market presence.
- The success of Lowell Farms pre-rolls and Wana gummies demonstrates the importance of brand building and product differentiation in the cannabis industry.
Stakeholder Impact
- Shareholders may be concerned about the decreased profitability and cash flow in Q4 2023.
- Employees may be affected by cost optimization efforts.
- Customers may benefit from the company's focus on enhancing the retail experience.
- Suppliers may see increased demand due to the company's expansion.
- Creditors may be concerned about the increase in total debt.
Next Steps
- The company will continue to elevate the customer experience.
- Schwazze will improve its loyalty program.
- The company will increase cost efficiencies.
- Schwazze will enhance its retail assets.
- The company will focus on driving growth and profitability across each of its markets in 2024.
Key Dates
| Date | Description |
|---|---|
| March 27, 2024 | Date of the press release announcing Q4 and full year 2023 financial results and the conference call. |
| April 1, 2024 | Lowell Farms products will be available for wholesale in New Mexico. |
| April 3, 2024 | Date the 8-K report was signed. |
Keywords
cannabis, Schwazze, dispensaries, retail, wholesale, EBITDA, revenue, Colorado, New Mexico, financial results
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.